Sydnexis has announced FDA acceptance of its ?????? ???????? ?????????????????????? (??????) ?????? ??????-??????, with a PDUFA date set for the ?????????????????? ???? ?????????????????? ???????????? ??????????????????????—a condition impacting approximately 28 million children in the U.S. alone. ? With myopia prevalence and severity rising due to lifestyle and environmental factors, SYD-101 could become the first and only FDA-approved treatment designed to slow its progression, offering a much-needed solution for children and their families. ? https://lnkd.in/gfh7mZcW Perry J. Sternberg, Patrick Johnson, Nick Ruth #Ophthalmology #Myopia #Sydnexis #SYD101 #FDA #EyeHealth #Innovation
Ophthalmology Innovation Source
媒体制作
Jericho，NY 7,204 位关注者
Facilitating connections between corporate, capital and clinical leaders to accelerate ophthalmic innovations.
关于我们
The Ophthalmology Innovation Summits facilitate meaningful interactions and the exchange of information between clinical, capital and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.
- 网站
-
https://ois.net/
Ophthalmology Innovation Source的外部链接
- 所属行业
- 媒体制作
- 规模
- 11-50 人
- 总部
- Jericho，NY
- 类型
- 私人持股
- 创立
- 2009
- 领域
- Ophthalmology、Ophthalmology Summit和Ophthalmology Conferences
地点
-
主要
获取路线
US，NY，Jericho，11753
Ophthalmology Innovation Source员工
动态
-
We at ?????? couldn’t be more thrilled to congratulate Neurotech Pharmaceuticals, Inc. on receiving ?????? ???????????????? for ??????????????? (???????????????????????? ????????????????????-????????) as a groundbreaking treatment for ?????????????? ???????????????????????????? ???????? ?? (????????????)! This milestone is a testament to Neurotech’s dedication to innovation and their unwavering commitment to addressing unmet needs in retinal disease treatment. We’ve had the privilege of witnessing Neurotech’s journey firsthand, and this achievement reinforces the incredible potential of cutting-edge therapies in advancing eye care. ? https://lnkd.in/gkbYj_nw Laurie Ferguson Rich Small #OphthalmologyInnovation #NeurotechPharmaceuticals #FDA #EyeCare
-
Don't miss your chance to join top innovators, investors, and industry leaders at ?????? ???????????? ???????? on ?????????? ??????, where the latest advancements in ophthalmic innovation will take center stage. ???????????????? ?????????? to connect with key players, gain valuable insights, and explore emerging opportunities in the global eye care market! https://lnkd.in/gBvqZGcv #OISIsrael #Ophthalmology #Innovation #Ophthalmic
-
-
Exciting things are happening in ophthalmology! Pykus Therapeutics has expanded their patent portfolio for PYK-2101, a first-in-class retinal sealant technology designed to accelerate visual recovery, enhance surgical outcomes, and dramatically improve the post-operative experience for patients with retinal detachment. https://lnkd.in/gs5NuKVu #PykusTherapeutics #Ophthalmology #Innovation
Pykus Therapeutics expands the patent portfolio for PYK-2101, our First-in-class Retinal Sealant Technology for rapid visual recovery, enhanced outcomes, and a dramatically improved post-operative experience for patients with retinal detachment. The newly issued patent further strengthens Pykus’ global intellectual property portfolio of more than a dozen! issued and pending patents through 2044. Read the full press release here: https://lnkd.in/ej6phEDs Learn more about how the investigational biodegradable hydrogel sealant PYK-2101 works: https://lnkd.in/exJM3k5Q #RetinaSurgery #Ophthalmology #FightBlindness #seebetterlivebetter #MedTech #RetinaRedefined #RetinalDetachment #Innovation #SeeBrilliantly #HealthcareInnovation #VisionCare #CambridgeMA #MassGeneralBrigham
-
2025 marks our 15th year, and one of our greatest joys has been witnessing companies grow from inception to this! Please join us in congratulating Oculis and Riad SHERIF - a respected member of the innovation community - on a banner start to 2025! We look forward to keeping up with the next 10 months, Team Oculis!
Very pleased to share the news of a $100 million oversubscribed offering to fuel the growth of Oculis’ portfolio, particularly the progress of Privosegtor (OCS-05), a groundbreaking neuroprotective candidate. In early January, we unveiled the promising top-line outcomes from the Phase 2 ACUITY trial, demonstrating Privosegtor’s neuroprotective impact on both anatomical and visual functions in patients with acute optic neuritis. The results also underscored its potential broad application across various neuro-ophthalmic and neurological conditions like glaucoma, neurotrophic keratitis, and multiple sclerosis. A heartfelt thank you to all our existing and new investors for their incredible backing. This funding round will catapult Oculis to new horizons, empowering us to push our pipeline forward and accelerate the advancement of Privosegtor (OCS-05) For more information, read the full press release:?https://bit.ly/40ZYTEV ? #Oculis #ClinicalTrial #Biotech #DrugDevelopment #Ophthalmology #Biopharma #RethinkingOphthalmology #financing #Nasdaq #OCS-05 #Privosegtor #Neuroprotection
-
-
Exciting news from Pykus Therapeutics as they prepare to present initial clinical data on PYK-2101, a novel retinal sealant, at the ???????? ???????????????????? ???????? meeting! Innovation in retinal surgery continues to advance, and we’re thrilled to see groundbreaking solutions like this shaping the future of ophthalmology. https://lnkd.in/e2PgxTk6 #Ophthalmology #PykusTherapeutics #Innovation #RetinalSurgery
-
In this episode of Eye on Innovation Podcast, host Carey Powers launches the Next-Gen Innovators series with Dr. Vikram Shankar, Stanford ophthalmologist and co-founder of Drop Mate, Inc., to explore how this groundbreaking device is transforming clinical disinfection—saving time, reducing waste, and setting a new standard in eye care. Tune in now! https://lnkd.in/ducKC6ZF #OIS #OISPodcast #Ophthalmology #Innovation #CareyPowers #VikramShankar #DropMate
-
-
The The Collaborative Community on Ophthalmic Innovation is hosting its 5th International Meeting, a virtual conference on ?????????????? ????-????, ????????, titled "?????? ?????????????????? ???? ???????????????????? ???? ?????? ????????????????????." This two-day event will gather global experts from academia, government, patient groups, and industry to dive into the latest advancements in AI and cutting-edge technologies transforming eye care. Explore the program and revisit past events here: www.cc-oi.org Don’t miss out on this exciting opportunity to engage with thought leaders shaping the future of ophthalmology! #Ophthalmology #Innovation #AI #EyeCare #CCOI2025
-
-
Oculis announces positive Phase 2 results for OCS-05 in the ACUITY trial, marking a significant milestone in treating acute optic neuritis.? Read the full release for details: https://lnkd.in/g845gfGe #Oculis #OpticNeuritis #ClinicalTrials #InnovationInEyeCare
-
In this week's OIS Podcast episode, we’re diving into ?????? ?????????? ???? ??????????????????????????: ???????? ??????????-?????????? ???????????????????? ???? ???????????????????? ????????????????! ?????? ???? ???????????????????? host Carey Powers brings you a special double-feature episode featuring: Dr. Fran Lasowski of 20/20 OptimEyes Technologies and Dr. Wendy Naimark of Ripple Therapeutics sharing how strategic partnerships accelerate breakthroughs and tackle challenges in biotech development.?Tracy Valorie, biotech veteran, offering expert insights on why commercial strategy needs to begin day one, covering market access, reimbursement, and manufacturing readiness. Tune in now! https://lnkd.in/gCybsYrA #OIS #OISPodcast #Ophthalmology #Innovation #CareyPowers #FranLasowski #WendyNaimark #TracyValorie
-